Wellness by Michael Tomasini

Les mitochondries n'ont pas besoin d'un redémarrage — elles ont besoin de meilleurs apports.

Somebody on the internet will always promise a “mitochondria reset” that makes your diet work “2–3x better.” The universe is older than dirt and still hasn’t figured out how to do that.

Here’s the calmer, more useful truth:

Plateaus rarely mean your metabolism is broken. They usually mean your body is adapting—to lower energy intake, higher training stress, poor sleep, travel disruption, or some combo of the above.

This post is the “no-hype” map: what’s real, what’s speculative, and what actually helps—especially if you’re a busy professional trying to stay lean and perform while traveling.

1) The plateau problem: adaptation, not failure

When fat loss stalls, the body often reduces energy expenditure more than you’d predict from the weight you lost. That “downshift” is commonly called adaptive thermogenesis and is widely recognized as a major contributor to plateaus. 

Two important implications:

  • You can be trying hard and still slow down progress because your baseline burn rate and “background movement” (NEAT: non-exercise activity thermogenesis) quietly drop.
  • If you respond by stacking more stress (more fasting + more HIIT + less sleep), you can make the system even harder to manage.

For endurance-minded people: this isn’t only a sedentary-person problem. The IOC consensus on RED-S (Relative Energy Deficiency in Sport) highlights how chronic low energy availability can impair health and performance across multiple systems. 

There’s also legitimate debate about how well RED-S is measured in the field (important nuance), but the overall warning sign is useful: training demand has to match fueling + recovery. 

2) “Metabolic flexibility” is real—just not magical

The influencer script often says you’re “stuck” because you can’t switch between carbs and fat. The underlying biology has real control points:

  • PDH (pyruvate dehydrogenase) helps route carbohydrate-derived fuel into oxidation; PDK enzymes (often discussed: PDK4) inhibit PDH activity, pushing metabolism away from glucose oxidation.  
  • CPT1 is a gatekeeper for fatty acid entry into mitochondria, and malonyl-CoA inhibits CPT1 (classic metabolic regulation).  

But here’s the key correction:

These mechanisms don’t create a single diagnosis called “metabolic gridlock.” In real life, plateaus typically reflect a blend of:

  • adaptive thermogenesis  
  • recovery debt (sleep/circadian disruption, stress load)
  • behavior drift (smaller portions become bigger, steps drop, travel snacks appear like gremlins)

So we use the science as a compass, not a fairy tale.

3) Light & mitochondria: where the evidence is strongest

Photobiomodulation (PBM)—red and near-infrared light applied at controlled doses—has a real peer-review base. One widely discussed pathway involves mitochondrial cytochrome c oxidase and nitric oxide signaling. 

WbMT translation:

PBM is not a “reboot.” It’s a tool that may support recovery and function in certain contexts. Dose and expectations matter.

The “EZ-water battery” theory: interesting, not settled

Exclusion zone (EZ) water phenomena near hydrophilic surfaces have been demonstrated in lab experiments—but the bigger claims (EZ as a major biological energy transducer) are debated. A critical review summarizes evidence for EZ phenomena and also covers alternative explanations and gaps. 

There is also experimental work showing radiant energy (including IR) can expand exclusion zones in model systems. 

That’s fascinating physics—but it’s not a license to say your mitochondria are “charged like a battery” in everyday human biology.

WbMT stance: PBM = evidence-leaning tool. EZ-water-as-metabolic-battery = speculative storyline.

4) The “advanced hack” trap: where we draw a hard line

Some videos jump from reasonable ideas straight into “just take methylene blue” or “consider peptides.”

That’s where credibility and safety matter.

Methylene blue

Methylene blue has medical uses, but it’s also a monoamine oxidase inhibitor (MAOI) and can precipitate serotonin toxicity when combined with serotonergic medications (SSRIs/SNRIs, etc.). 

So “low dose is very safe” as general wellness advice is not responsible.

MOTS-c and peptides

Mitochondria-derived peptides are a legit research frontier, but consumer peptide protocols are not the same thing as established clinical practice. For WbMT: interesting science, not DIY metabolism repair.

5) The WbMT “Better Inputs” protocol (travel-proof and boring-on-purpose)

Here’s the part you can actually use this week.

Input 1: Energy availability (especially if you train)

If you diet aggressively while training hard, plan maintenance days and deload weeks rather than stacking stress indefinitely. Adaptive thermogenesis is a known plateau mechanism. 

For athletes, the IOC consensus keeps the caution flag up around chronic low energy availability. 

Input 2: Protect NEAT (steps) on travel weeks

Travel steals movement. Put a floor under it: short walks after meals, airport laps, “meeting-to-meeting steps.”

Input 3: Circadian anchors

Morning outdoor light + light movement as early as possible. This is the cheapest “mitochondria-friendly” input you’ll ever get.

Input 4: Training stress needs recovery stress-buffer

Don’t stack: long fast + HIIT + low sleep + caffeine + deadline week. Rotate stress and recovery on purpose.

Optional tool: PBM (red/NIR)

If you already use it, keep it modest and consistent—think “recovery support,” not “metabolic reset.” 

WbMT rule: tools, not religion—and definitely not magic.

Références

  • Weight-loss plateaus and adaptive thermogenesis overview (StatPearls/NCBI).  
  • IOC Consensus Statement on RED-S (2023).  
  • Critical review on RED-S concept and field measurement issues (2024).  
  • PBM mechanisms involving cytochrome c oxidase / nitric oxide (review).  
  • EZ water critical review (IJMS 2020).  
  • Radiant energy expanding EZ in model systems (2009) and IR effects on interfacial water (2021).  
  • Methylene blue as MAOI and serotonin toxicity risk + FDA safety communication.  

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *